0000899243-21-036427.txt : 20210917
0000899243-21-036427.hdr.sgml : 20210917
20210917164408
ACCESSION NUMBER: 0000899243-21-036427
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210917
FILED AS OF DATE: 20210917
DATE AS OF CHANGE: 20210917
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: van den Boom Esther
CENTRAL INDEX KEY: 0001603563
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40800
FILM NUMBER: 211260983
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 1150
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tyra Biosciences, Inc.
CENTRAL INDEX KEY: 0001863127
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831476348
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2656 STATE STREET
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: (619) 728-4760
MAIL ADDRESS:
STREET 1: 2656 STATE STREET
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-09-17
0
0001863127
Tyra Biosciences, Inc.
TYRA
0001603563
van den Boom Esther
C/O TYRA BIOSCIENCES, INC.
2656 STATE STREET
CARLSBAD
CA
92008
0
1
0
0
Chief Financial Officer
Common Stock
2021-09-17
4
C
0
21254
A
21254
I
See footnote
Common Stock
118645
D
Series A Preferred Stock
2021-09-17
4
C
0
8183
0.00
D
Common Stock
21254
0
D
On September 17, 2021, each share of Series A Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
Represents shares held by van den Boom Ventures LLC, of which the spouse of the Reporting Person is the managing member.
Includes 71,674 shares subject to repurchase by us, which are subject to vesting.
/s/ John Healy, Attorney-in Fact
2021-09-17